MedTrace Logo

Oral Liposomal Glutathione Supplementation in Healthy Subjects

NCT02278822 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2016-07-11

No results posted yet for this study

Summary

This trial is designed to provide evidence of the efficacy of liposomal glutathione supplementation on healthy adults. The investigators anticipate that liposomal glutathione supplementation will enhance the levels of blood glutathione and improve the immune functions.

Conditions

  • Healthy

Interventions

OTHER

Low dose oral liposomal glutathione supplementation

Low dose oral liposomal glutathione supplementation

OTHER

High dose oral liposomal glutathione supplementation

High dose oral liposomal glutathione supplementation

Sponsors & Collaborators

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Raghu Sinha, PhD · M.S. Hershey Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-04-30
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02278822 on ClinicalTrials.gov